News Image

Which stocks are moving on Tuesday?

By Mill Chart

Last update: Sep 27, 2022

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.

Gainers

TickerChangeComment
KPRX3.0K%KIORA PHARMACEUTICALS INC's (NASDAQ:KPRX) shares rose 3.0K% to $6.12. In the last 3 months the share price dropped with 60.22%.
ATXI165.0%AVENUE THERAPEUTICS INC (NASDAQ:ATXI) rose 165.0% to $9.32 during Tuesday's after hours session. Shareholders saw the stock price going 45.43% lower is the past 6 months.
SJ44.32%SCIENJOY HOLDING CORP-A's (NASDAQ:SJ) shares rose 44.32% to $2.41. The stock is trading 52.29% lower than a month ago.
CRH.W38.0%COHN ROBBINS HOLDINGS -CW25's (NYSE:CRH.W) stock price is advancing with 38.0% to a price of $0.02. In the last month the stock lost 97.03%.
INM37.96%INMED PHARMACEUTICALS INC's (NASDAQ:INM) shares rose 37.96% to $7.05 during Tuesday's session. In the last month the stock lost 21.41%.
SONX35.97%SONENDO INC (NYSE:SONX) rose 35.97% to $1.59 during Tuesday's after hours session. In the last month the stock gained 27.51%.
XFOR33.71%X4 PHARMACEUTICALS INC's (NASDAQ:XFOR) stock price is advancing with 33.71% to a price of $1.19. Shareholders saw the stock price going 52.82% lower is the past 6 months.
ILAG30.64%INTELLIGENT LIVING APPLICATI's (NASDAQ:ILAG) stock price increased by 30.64% to $2.67. In the last month the share price dropped with 30.38%.
GROV27.7%GROVE COLLABORATIVE HOLDINGS (NYSE:GROV) rose 27.7% to $3.78 during Tuesday's after hours session. A press release (Grove Co. Continues Retail Expansion with Entry Into Thousands of More Stores) was released earlier today.
FWBI20.62%FIRST WAVE BIOPHARMA's (NASDAQ:FWBI) shares rose 20.62% to $1.63 during Tuesday's session. Yesterday the company had a press release: First Wave BioPharma Stock Bid Higher After Adrulipase Study Update; Expects To File IND Application In Q4 ($FWBI).

For the full top gainers list go to our top gainers screener.

Top losers

TickerChangeComment
GSMGW-30.0%GLORY STAR NEW -CW25's (NASDAQ:GSMGW) stock price decreased by 30.0% to $0.01. In the last month the stock gained 23.46%.
LCFY-23.18%LOCAFY LTD's (NASDAQ:LCFY) stock price is declining with 23.18% to a price of $0.34. The stock is trading 28.25% lower than a month ago.
FNHC-22.64%FEDNAT HOLDING CO's (NASDAQ:FNHC) shares fell 22.64% to $0.17 during Tuesday's session. The stock is trading 36.63% lower than a month ago.
NLSP-21.96%NLS PHARMACEUTICS LTD's (NASDAQ:NLSP) shares fell 21.96% to $0.75 during Tuesday's session. In the last month the stock gained 89.02%.
EVEX-19.37%EVE HOLDING INC's (NYSE:EVEX) stock price decreased by 19.37% to $9.91. In the last month the share price increased with 78.37%.
MTP-18.85%MIDATECH PHARMA PLC-ADR's (NASDAQ:MTP) stock price is declining with 18.85% to a price of $2.11. In the last month the share price increased with 256.0%.
BOA.W-16.67%BOA ACQUISITION CL A -CW28's (NYSE:BOA.W) stock price decreased by 16.67% to $0.11. The stock is trading 108.0% higher than a month ago.
ELOX-16.67%ELOXX PHARMACEUTICALS INC's (NASDAQ:ELOX) shares fell 16.67% to $0.15. The stock is trading 53.28% lower than a month ago.
GSUN-16.43%GOLDEN SUN EDUCATION GROUP-A's (NASDAQ:GSUN) shares fell 16.43% to $34.03 during Tuesday's session. In the last month the share price increased with 27.61%.
KTRA-15.84%KINTARA THERAPEUTICS INC's (NASDAQ:KTRA) shares fell 15.84% to $0.11 during Tuesday's session. Shareholders saw the stock price going 46.51% lower in the past 3 months.

Our top losers screener will show you the full list.

Back

AVENUE THERAPEUTICS INC

NASDAQ:ATXI (4/25/2024, 8:35:50 PM)

After market: 0.117 0 (0%)

0.117

+0.02 (+24.07%)

ATXI News

News Image6 hours ago - ChartmillGet insights into the top gainers and losers of Thursday's after-hours session.

Which stocks are moving after the closing bell on Thursday?

News Imagea day ago - ChartmillTop movers in Wednesday's session

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

News Image2 days ago - ChartmillTraders are paying attention to the gapping stocks in Wednesday's session. Let's dive into which stocks are experiencing notable gaps.

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.

News Image2 days ago - Avenue TherapeuticsAvenue Therapeutics Announces Reverse Stock Split

MIAMI, April 24, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

News Image16 days ago - ChartmillTop movers in Tuesday's after hours session

Get insights into the top gainers and losers of Tuesday's after-hours session.

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

News Imagea month ago - BusinessInsiderATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Avenue Therapeutics (NASDAQ:ATXI) just reported results for the fourth quarter ...

News Imagea month ago - InvestorPlaceATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023

ATXI stock results show that Avenue Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

- Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in second quarter of 2024 - ...

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics Receives Positive Listing Determination from Nasdaq

MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

News Image2 months ago - Avenue TherapeuticsAvenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

BAER-101 demonstrated full suppression of seizure activity in SynapCell's GAERS model of absence epilepsy, a proven indicator of efficacy in anti-seizure...

News Image2 months ago - Avenue TherapeuticsAvenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

-In vivo data supports BAER-101’s unique ability to significantly suppress seizures using the SynapCell's Genetic Absence Epilepsy Rat from Strasbourg...

ATXI Links
Follow us for more